|
|
Clinical Effect of Dachaihu Decoction on Acute Pelvic Inflammation and its Effect on Secretory Immunoglobulin A and Serum CRP |
ZHANG Yamin, ZHANG Liran, et al |
Heilongjiang Provincial Hospital of Traditional Chinese Medicine / Heilongjiang College of Traditional Chinese Medicine, Heilongjiang Harbin 150000, China |
|
|
Abstract Objective: To investigate the clinical effect of Dachaihu Decoction on acute pelvic inflammation and its effect on serum secretory immunoglobulin A(sIgA) and C-reactive protein(CRP). Methods: 144 patients with acute pelvic inflammatory disease from December 2018 to May 2020 were randomly divided into two groups, 72 cases in each group. The control group was treated with cefoxitin sodium and doxycycline hydrochloride. The observation group was treated with Dachaihu Decoction on the basis of the control group. The pelvic effusion, pelvic mass, serum inflammatory factors [CRP, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6)] and sIgA before and after treatment were compared between the two groups. The clinical efficacy and the occurrence of adverse reactions during treatment were recorded and compared between two groups. Results: The effective rate of treatment in the observation group was higher than that in the control group (97.22% vs.84.72%) (P<0.05). Compared with before treatment, the level of pelvic effusion and pelvic mass in the observation group and the control group after treatment were decreased (P<0.05), and the level of pelvic effusion and pelvic mass in the observation group was lower than that in the control group (P<0.05). The levels of CRP, TNF-α and IL-6 in the observation group after treatment were lower than those in the control group, and the levels of sIgA were higher than that in the control group (P<0.05). The rate of adverse reactions in the observation group during treatment was lower than that in the control group (8.33% vs 20.83%)(P<0.05). Conclusion: Dachaihu decoction has better clinical efficacy in the treatment of acute pelvic inflammation, reducing pelvic effusion and pelvic mass size, reducing body inflammatory factors and improving immune function, and reducing the adverse reactions, which is worthy of promotion.
|
|
|
|
|
[1] McKee DL,Hu Z,Stahlman S,et al. Incidence and sequelae of acute pelvic inflammatory disease among active component females,U.S. armed forces,1996~2016[J].MSMR,2018,25(10):2~8. [2] Curry A,Williams T,Penny ML,et al. Pelvic inflammatory disease:diagnosis,management,and prevention[J].Am Fam Physician,2019,100(6):357~364. [3] Haggerty CL,Ness RB,Totten PA,et al. Presence and concentrations of select bacterial vaginosis-associated bacteria are associated with increased risk of pelvic inflammatory disease[J].Sex Transm Dis,2020,47(5):344~346. [4] 李晓红,龙旭,李芳.盆炎舒方联合盐酸克林霉素对急性盆腔炎患者TGF-β1、IL-18和CRP的影响[J].西部中医药,2019,32(11):57~60. [5] 中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(2019修订版)[J].中华妇产科杂志,2019,54(7):433~437. [6] Kulavsky KVA,Ziganshin ZAM,Kulavsky KEV. Prevention of adhesion in women with acute pelvic inflammatory diseases:clinical aspects[J]. Akush Ginekol (Mosk),2019,36(8):476~482. [7] Borchsenius SN,Daks A,Fedorova O,et al. Effects of mycoplasma infection on the host organism response via p53/NF-κB signaling[J].Cell Physiol,2019,234(1):171~180. [8] Piao J,Lee EJ,Lee M,et al. Association between pelvic inflammatory disease and risk of ovarian cancer:An updated meta-analysis[J]. Gynecol Oncol,2020,157(2):542~548. [9] Hu JJ,Urbanic JJ,Case LD,et al. Association between inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in a multiracial/ethnic breast cancer population[J].Clin Oncol,2018,36(24):2473~2482. [10] Wang D,Zhang J,Sun Y,et al. Long non-coding RNA NKILA weakens TNF-α-induced inflammation of MRC-5 cells by miR-21 up-regulation[J].Artif Cells Nanomed Biotechnol,2020,48(1):498~505. [11] Kusumo PD,Bela B,Wibowo H,et al. Lactobacillus plantarum IS-10506 supplementation increases faecal sIgA and immune response in children younger than two years[J].Benef Microbes,2019,10(3):245~252. [12] 邓玉红,陈锦锋,佘玲,等.加味大柴胡汤治疗急性胆囊炎(胆腑郁热证)的临床研究[J].中国中医急症,2018,27(3):462~464. [13] 潘丽华,陈少君.清热祛湿化瘀汤联合康妇消炎栓对湿热瘀结型盆腔炎性患者中医证候、血清炎症因子及不良反应的影响[J].四川中医,2019,37(2):173~175. |
|
|
|